Aandeel 4114 SYNMOSA BIOPHARMA CORPORATION
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Synmosa Biopharma Corporation

Aandelen

4114

TW0004114004

slotkoers Taipei Exchange
Andere beurzen
 00:00:00 10-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
39,55 TWD +1,15% Intraday-grafiek van Synmosa Biopharma Corporation +2,06% +2,33%
29/03 Synmosa Biopharma Corporation rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
16/01 Synmosa Biopharma Corporation kondigt wijzigingen aan in de vijfde zitting van de remuneratiecommissie CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Member of the Audit Committee
Synmosa Biopharma Corporation announced that it expects to receive TWD 950 million in funding
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022
Synmosa Biopharma Corporation Announces Changes of Corporate Governance Officer
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Synmosa Biopharma : The Company is invited to attend institutional investor conference held by IBF Securities
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
Synmosa Biopharma : Announcement of the Company's board of directors resolution on transfer treasury shares to employees and the record date of share subscription
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 4114
  4. Nieuws Synmosa Biopharma Corporation
  5. Andere talen